Skip to main content

2024 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Joseph Custodio, Ph.D.

Sr. Director
Corcept Therapeutics

Poster(s):

(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects

Tuesday, October 22, 2024
1:30 PM – 2:30 PM MT